Trademark: 88166343
Word
HELIXMITH
Status
Registered
Status Code
700
Status Date
Tuesday, November 12, 2019
Serial Number
88166343
Registration Number
5906698
Registration Date
Tuesday, November 12, 2019
Mark Type
4000
Filing Date
Tuesday, October 23, 2018
Published for Opposition
Tuesday, May 28, 2019

Trademark Owner History
Helixmitth Co., Ltd - Original Registrant
ViroMed Co., Ltd. - Owner At Publication

Classifications
5 reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugs, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicines for human purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; crude medicines, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer
35 Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents, retail store services featuring biological preparations for medical use
42 Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services
In the statement, Column 1, line 1-3,"are deleted", and HELIXMITH CO., LTD (Korea, republic of Corporation) 1 Gwanak-ro 5th Fl. Bldg. 203, Seoul, Korea, South 08826 should be inserted
HELIX MITH

Trademark Events
Aug 25, 2020
Correction Under Section 7 - Processed
Aug 10, 2020
Teas Response To Office Action-Post Reg Received
Feb 19, 2020
Post Registration Action Mailed - Sec. 7
Feb 18, 2020
Case Assigned To Post Registration Paralegal
Feb 18, 2020
Post Registration Action Correction
Feb 18, 2020
Otqr Withdrawal From Publication
Jan 21, 2020
Correction Under Section 7 - Processed
Jan 21, 2020
Case Assigned To Post Registration Paralegal
Dec 3, 2019
Teas Section 7 Request Received
Nov 12, 2019
Registered-Principal Register
Oct 6, 2019
Extension Of Time To Oppose Process - Terminated
Jun 19, 2019
Assignment Of Ownership Not Updated Automatically
Jun 11, 2019
Extension Of Time To Oppose Received
May 28, 2019
Official Gazette Publication Confirmation E-Mailed
May 28, 2019
Published For Opposition
May 8, 2019
Notification Of Notice Of Publication E-Mailed
Apr 22, 2019
Electronic Record Review Complete
Apr 12, 2019
On Hold - Electronic Record Review Required
Apr 3, 2019
Approved For Pub - Principal Register
Apr 3, 2019
Examiner's Amendment Entered
Apr 3, 2019
Notification Of Examiners Amendment E-Mailed
Apr 3, 2019
Examiners Amendment E-Mailed
Apr 3, 2019
Examiners Amendment -Written
Mar 30, 2019
Teas/Email Correspondence Entered
Mar 29, 2019
Correspondence Received In Law Office
Mar 29, 2019
Teas Response To Office Action Received
Mar 22, 2019
Notification Of Non-Final Action E-Mailed
Mar 22, 2019
Non-Final Action E-Mailed
Mar 22, 2019
Non-Final Action Written
Mar 13, 2019
Teas/Email Correspondence Entered
Mar 13, 2019
Correspondence Received In Law Office
Mar 8, 2019
Assigned To Lie
Mar 5, 2019
Teas Response To Office Action Received
Jan 5, 2019
Notification Of Non-Final Action E-Mailed
Jan 5, 2019
Non-Final Action E-Mailed
Jan 5, 2019
Non-Final Action Written
Jan 3, 2019
Assigned To Examiner
Nov 5, 2018
New Application Office Supplied Data Entered
Oct 26, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24